focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,222.00
Bid: 12,218.00
Ask: 12,224.00
Change: 126.00 (1.04%)
Spread: 6.00 (0.049%)
Open: 12,150.00
High: 12,266.00
Low: 12,134.00
Prev. Close: 12,096.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EU's von der Leyen tells skittish Europeans: 'I'd take AstraZeneca vaccine'

Tue, 23rd Feb 2021 23:04

BERLIN, Feb 23 (Reuters) - The European Union's most senior
administrator said she would happily receive AstraZeneca's
coronavirus vaccine as officials rushed to find ways of
ensuring doses refused by skittish Germans did not go to waste.

President of the European Commission Ursula von der Leyen's
remarks came amid growing concerns that unfavourable comments by
top European officials including French President Emmanuel
Macron had slowed take-up of one of only three vaccines
currently approved EU-wide.

Earlier this month, Macron said Britain had taken a risk in
authorising AstraZeneca so rapidly. A German official study also
found evidence that, though effective, the vaccine has more
severe side effects than its two main rivals.

"I would take the AstraZeneca vaccine without a second
thought, just like Moderna's and BioNTech/Pfizer's
products," von der Leyen told the Augsburger
Allgemeine.

The endorsement is all the more striking for coming a month
after the European Commission that she heads entered into sharp
correspondence with AstraZeneca over suggestions, denied by the
company, that the British-Swedish company had prioritised
Britain over the EU in delivering the vaccine.

The Commission has been criticised over the slow pace of
vaccination across the 27-member-bloc, with critics saying it
failed to secure sufficient early supply of the vaccines that
leaders are banking on to bring an end to the pandemic that has
devastated the continent's economy.

In Germany, where a widespread preference for the
German-designed BioNTech vaccine has led to a growing number of
unused AstraZeneca doses, officials and politicians competed to
suggest ways of making sure they did not go to waste.

Berlin's Social Affairs Senator Elke Breitenbach said unused
doses should be given to the 3,000 homeless living in the city's
emergency accommodation. "We shouldn't forget those who don't
have a loud lobby behind them," she told Funke Media Group.

Interior Minister Horst Seehofer had earlier said unused
vaccines should go to the police.
(Reporting by Thomas Escritt; Editing by Cynthia Osterman)

More News
27 Dec 2023 07:52

LONDON BRIEFING: AstraZeneca buys Gracell Biotech; COPL CEO resigns

(Alliance News) - Stocks in London were expected to make gains at Wednesday's market open, as investors continued to pin their hopes on US interest rate cuts.

Read more
27 Dec 2023 07:02

AstraZeneca to buy Gracell Technologies for $1.2bn

(Sharecast News) - AstraZeneca on Wednesday said it was buying Gracell Biotechnologies, a global clinical-stage biopharmaceutical company developing cell therapies for the treatment of cancer and autoimmune diseases, for $1.2bn.

Read more
26 Dec 2023 21:26

Wall Street ends higher in final stretch of 2023, rate cuts in view

Intel up on $3.2 bln grant from Israel

*

Read more
26 Dec 2023 21:00

Wall Street ends higher in final stretch of 2023, rate cuts in view

Intel up on $3.2 bln grant from Israel

*

Read more
26 Dec 2023 19:41

Wall Street gains on final stretch of 2023, rate cuts in view

Intel up on $3.2 bln grant from Israel

*

Read more
22 Dec 2023 08:47

AstraZeneca, Ionis get US FDA nod for Wainua in "important milestone"

(Alliance News) - AstraZeneca PLC and Ionis Pharmaceuticals Inc on Friday celebrated the news that their drug eplontersen was approved by the US Food & Drug Administration.

Read more
22 Dec 2023 07:50

LONDON BRIEFING: UK on brink of recession as economy contracts in Q3

(Alliance News) - Stocks in London are likely to open lower on Friday, with investors feeling frosty ahead of a US inflation print this afternoon, amid sobering UK economic growth data.

Read more
22 Dec 2023 07:17

AstraZeneca gets FDA green light for nerve disease treatment

(Sharecast News) - The US Food and Drug Administration has approved the Wainua nerve disease treatment jointly developed by AstraZeneca and Ionis Pharmaceuticals.

Read more
19 Dec 2023 19:56

US adds 13 companies in China to Unverified List

WASHINGTON, Dec 19 (Reuters) - The United States has added 13 companies in China to a list of entities receiving U.S. exports that officials have been unable to inspect, according to a government notice posted on Tuesday.

Read more
15 Dec 2023 17:14

London stocks log weekly gains as cenbank fest ends

FTSE 100 down 1.0%, FTSE 250 off -0.3%

*

Read more
15 Dec 2023 16:51

LONDON MARKET CLOSE: FTSE 100 underperforms as post-Fed rally cools

(Alliance News) - London's FTSE 100 ended lower on Friday, with profit-taking and some hawkish words from a US policymaker keeping equities in check at the end of a largely positive week for stocks.

Read more
15 Dec 2023 16:29

PRESS: GSK, Astra and AbbVie in US scrutiny over patents - Bloomberg

(Alliance News) - A US senator has accused AstraZeneca PLC, GSK PLC, AbbVie Inc and other drugmakers of "abusing" the patent system to send prices higher, Bloomberg reported on Thursday.

Read more
13 Dec 2023 17:07

UK's FTSE 100 rises as pound slips on GDP data; awaits Fed rate decision

UK economy shrinks by 0.3% in October

*

Read more
12 Dec 2023 16:00

London close: Stocks slip as investors digest US inflation

(Sharecast News) - London's markets finished in the red on Tuesday, as investors digested a slight decrease in consumer inflation in the US, while the UK's unemployment figures remained stable.

Read more
12 Dec 2023 12:07

London midday: FTSE still firmer ahead of US inflation print

(Sharecast News) - London's markets remained relatively stable by midday on Tuesday, with the top-flight index still in the green after fresh jobs data showed a slowdown in wage growth.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.